Pharmacokinetics of mirtazapine from orally administered tablets: Influence of gender, age and treatment regimen

Human Psychopharmacology

Volumn 11, Issue 6, 1996, Pages 497-509

  Timmer, C J ^a   Paanakker, J E ^a   Van Hal, H J M ^a  

^a NV ORGANON   (Netherlands)

Author keywords

antidepressant; mirtazapine; Org 3770; pharmacokinetics

Indexed keywords

MIRTAZAPINE;

ADULT; AGE; AGED; ARTICLE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEX;

EID: 0030460935     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199611)11:6<497::AID-HUP820>3.0.CO;2-J     Document Type: Article

References (38)

1. Abernathy, D. R., Greenblatt, D. J. and Shader, R. I. (1985). Imipramine and desipramine disposition in the elderly. Journal of Pharmacology and Experimental Therapeutics, 232, 183-188.
2. Altamura, A. C., Moro, A. R. and Percudani, M. (1994). Clinical pharmacokinetics of fluoxetine. Clinical Pharmacokinetics, 26, 201-214.
3. Bremner, J. D. (1995). A double-blind comparison of Org 3770, amitriptyline and placebo in major depression. Journal of Clinical Psychiatry, 56, 519-525.
4. Burrows, G., Scoggings, B. A. and Turacek, L. R. (1974). Plasma nortriptyline and clinical response. Clinical Pharmacology and Therapeutics, 16, 639-644.
5. Claghorn, J. L. and Lessem, M. D. (1995). A double-blind placebo controlled study of Org 3770 in depressed outpatients. Journal of Affective Disorders, 34, 165-171.
6. Dawkins, K. (1995). Gender differences in psychiatry. CNS Drugs, 3, 393-407.
7. Dawkins, K. and Potter, W. Z. (1991). Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: Focus on women. Psychopharmacology Bulletin, 27, 417-426.
8. 1A-mediated serotonergic neurotransmission. CNS Drugs, 4 (Suppl. 1), 29-38.
9. De Boer, T., Maura, G., Raiteri, M., De Vos, C. J., Wieringa, J. and Pinder, R. M. (1988). Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology, 27, 399-408.
10. 2 antagonist Org 3770 enhances serotonin transmission in vivo. European Journal of Pharmacology, 253, R5-6.
11. De Montigny, C., Haddjeri, N., Mongeau, R. and Blier, P. (1995). The effects of mirtazapine on interactions between central noradrenergic and serotonergic systems. CNS Drugs, 4 (Suppl. 1), 13-17.
12. Ereshefsky, L., Saklad, S. R., Watanabe, M. D., Davis, C. M. and Jann, M. W. (1991). Thiothixene pharmacokinetic interactions: a study of hepatic enzyme inducers, clearance inhibitors, and demographic variables. Journal of Clinical Psychopharmacology, 11, 296-301.
13. Gex-Fabry, M., Balant-Gorgia, A. E. and Balant, L. P. (1990). Clomipramine metabolism: model based analysis of variability factors from drug monitoring data. Clinical Pharmacokinetics, 19, 241-255.
14. Greenblatt, D. J., Friedman, H. and Burstein, E. S. (1987). Trazodone kinetics: effect of age, gender, and obesity. Clinical Pharmacology and Therapeutics, 42, 193-200.
15. Halikas, J. A. (1995). Org 3770 (mirtazapine) versus trazodone: a placebo controlled trial in depressed elderly patients. Human Psychopharmacology, 10 (Suppl. 2), S125-133.
16. Hammer, W. and Sjoqvist, S. (1967). Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sciences, 6, 1895-1903.
17. Haring, C., Meise, U., Humpel, C., Saria, A., Fleischhaker, W. W. and Hinterhuber, H. (1989). Dose-related plasma levels of clozapine: Influence of smoking behavior, sex and age. Psychopharmacology. 99 (Suppl. J), S38-40.
18. Harris, R. Z., Benet, L. Z. and Schwartz, J. B. (1995). Gender effects in pharmacokinetics and pharmacodynamics. Drugs, 50, 222-239.
19. Hoyberg, O. J., Maragakis, B., Mullin, J., Norum, D., Stordall, E., Ekdahl, P., Ose, E., Moksnes, K. M. and Sennef, C. (1996). A double blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychiatrica Scandinavica, 93, 184-190.
20. Kando, J. C., Yonkers, K. A. and Cole, J. O. (1995). Gender as a risk factor for adverse events to medications. Drugs, 50, 1-6.
21. 14C. Journal of Labelled Compounds and Radiopharmaceuticals, 27, 1055-1068.
22. Marttilla, M., Jääskeläinen, J., Järvi, R., Romanov, M., Miettinen, E., Sorri, P., Ahlfors, U. and Zivkov, M. (1995). A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression. European Neuropsychopharmacology, 5, 441-446.
23. Moody, J. P., Tait, A. C. and Todrick, A. (1967). Plasma levels of imipramine and desmethylimipramine during therapy. British Journal of Psychiatry, 113, 183-193.
24. Mullin, J., Lodge, A., Bennie, E., McCreadie, R., Bhatt, G. S. and Fenton, G. (1996). A multicentre, double-blind, amitriptyline-controlled study of mirtazapine in patients with major depression. Journal of Psychopharmacology, 10, 235-240.
25. Paanakker, J. E. and Van Hal, H. J. M. (1987). Capillary gas chromatographic assay for the routine monitoring of the antidepressant mepirzepine in human plasma. Journal of Chromatography, Biomedical Applications, 417, 203-207.
26. Preskorn, S. H. and Mac, D. S. (1985). Plasma levels of amitriptyline: Effect of age and sex. Journal of Clinical Psychiatry, 46, 276-277.
27. Richou, H., Ruimy, P., Charbaut, J., Delisle, J. P., Brunner, H., Patris, M. and Zivkov, M. (1995). A multicentre, double-blind, clomipramine-controlled efficacy and safety study of Org 3770. Human Psychopharmacology, 10, 263-271.
28. Simpson, G. M., Yadalam, K. G., Levinson, D. F., Stephanos, M. J., Sing Lo, E. E. and Cooper, T. B. (1990). Single dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. Journal of Clinical Psychopharmacology, 10, 417-421.
29. Sitsen, J. M. A., Zivkov, M. and Dieterle, D. (1995). Wirksamkeit und Verträglichkeit von Org 3770 bei Patienten mit einer Major Depression. Psychopharmakotherapie, 2, 68-71.
30. ® tablets. Human Psychopharmacology, 10 (Suppl. 2), S97-106.
31. Van Moffaert, M., De Wilde, J., Vereecken, A., Dierick, M., Evrarad, J. L., Wilmotte, J. and Mendlewicz, J. (1995). Mirtazapine is more effective than trazodone. A controlled study in hospitalised patients with major depression. International Clinical Psychopharmacology, 10, 3-9.
32. ® tablets after single and multiple oral dosing. Human Psychopharmacology, 10 (Suppl. 2), S83-96.
33. Warrington, S. J. (1991). Clinical implications of the pharmacology of sertraline. International Clinical Psychopharmacology, 6 (Suppl. 2), 11-21.
34. Wilson, K. (1984). Sex-related differences in drug disposition in man. Clinical Pharmacokinetics, 9, 189-202.
35. Yonkers, K. A., Kando, J. C., Cole, J. O. and Blumenthal, S. (1992). Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. American Journal of Psychiatry, 149, 587-595.
36. Zeigler, V. E. and Biggs, J. T. (1977). Tricyclic plasma levels: effects of age, race, sex, and smoking. Journal of the American Medical Association, 238, 2167-2169.
37. Zivkov, M. and De Jongh, G. (1995). Org 3770 vs amitriptyline: a 6-week, randomised double-blind multicentre trial in hospitalised patients. Human Psychopharmacology, 10, 263-271.
38. Zivkov, M., Roes, K. C. B. and Pols, A. G. (1995). Efficacy of Org 3770 (mirtazapine) vs amitriptyline in patients with major depressive disorder: a meta-analysis. Human Psychopharmacology, 10 (Suppl. 2), S135-145.